[HTML][HTML] Rare disease: cardiac risk assessment with MRI in patients with myotonic dystrophy type 1
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
M Ali, CB Monti, L Melazzini, R Cardani… - FRONTIERS IN …, 2020 - air.unimi.it
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
M Alì, CB Monti, L Melazzini, R Cardani… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
[引用][C] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
M Ali, CB Monti, L Melazzini, R Cardani… - … in Neurology (Web), 2020 - jglobal.jst.go.jp
Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular
basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3'end of a …
basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3'end of a …
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1.
M Alì, CB Monti, L Melazzini, R Cardani… - Frontiers in …, 2020 - europepmc.org
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
[PDF][PDF] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type
M Alì, CB Monti, L Melazzini, R Cardani, B Fossati… - fondazionemalattiemiotoniche.org
Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent
cardiac disease who had undergone cardiac magnetic resonance at our center. Patients …
cardiac disease who had undergone cardiac magnetic resonance at our center. Patients …
[引用][C] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
M Alì, CB Monti, L Melazzini, R Cardani, B Fossati… - Frontiers in …, 2020 - cir.nii.ac.jp
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
M Alì, CB Monti, L Melazzini, R Cardani… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …
[PDF][PDF] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type
M Alì, CB Monti, L Melazzini, R Cardani, B Fossati… - air.unimi.it
Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent
cardiac disease who had undergone cardiac magnetic resonance at our center. Patients …
cardiac disease who had undergone cardiac magnetic resonance at our center. Patients …